Indivior to Cut Board Size at May Shareholders' Meeting
Indivior Announces Strategic Board Restructuring
Indivior | 10-K: FY2024 Annual Report
Is Indivior PLC (INDV) the Best Small Cap Pharma Stock to Buy Now?
Trending Stocks Today | Longeveron Surges 25% Post-Market
Indivior Director Acquires 15,000 Shares, Signaling Confidence
Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating
Craig-Hallum Keeps Their Buy Rating on Indivior (INDV)
Indivior CEO Mark Crossley to Step Down, Joe Ciaffoni to Succeed
Indivior CEO to Step Down; Successor Named
Press Release: Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer
Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer >INDV.LN
Jefferies Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $12.35
Indivior PLC Sees Shift in Voting Rights With Morgan Stanley Acquisition
Express News | Indivior PLC Morgan Stanley - Holding(S) in Company
Indivior Gets FDA Approval for Faster Initiation of Opioid-Dependence Treatment, More Injection Options
Express News | FDA Approves Label Changes For Indivior's SUBLOCADE, Cutting Start Time To One Hour
Indivior's SUBLOCADE Receives FDA Approval for Rapid OUD Treatment Protocol
Indivior Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Indivior's Earnings Call: Growth Amidst Challenges